Fenilbutazon
保泰松
Report date: 2023/02/08 16:34:11
NME
Base Information
Drug NameFenilbutazon
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications +[4]
Global Approved Indications +[4]
Approved Indications in China +[4]
Original Approved Country/Territory
Original Approved Date1976/12/31
Country/Territory
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A
Develop Information
Active CompaniesHubei Pharmaceutical Co Ltd
Inactive CompaniesNovopharm Ltd
Active Indications +[4]
Inactive IndicationsN/A